Search
Dyadic International Aims to Hit $500,000 Revenue Milestone
2025-08-15 /
Read about 0 minute
Author：小编
Shares of biotechnology firm Dyadic International declined by 2.3%. The company revealed its anticipation of achieving a significant revenue milestone of $500,000 as it transitions into a commercial biotechnology enterprise. Recently, Dyadic International successfully completed a $5.3 million equity financing round and is now prioritizing the development of scalable protein production technology.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
